Our customers are involved in the food and beverage, health and nutrition, pharmaceutical, cosmetics and chemical industries
Mavrakanas has also received speaker honoraria from Bayer, Janssen, AstraZeneca, Novo Nordisk, and Boehringer-Ingelheim, and has served on advisory boards for Boehringer-Ingelheim, Servier, GSK, Novo Nordisk, and Bayer
Secondary outcomes included cardiovascular mortality, all-cause mortality, non-fatal myocardial infarction, non-fatal stroke, hospitalisation for heart failure, and adverse events
Das kann helfen, Blutzuckerspitzen nach den Mahlzeiten abzumildern
2,3,4,5 This review explores the current data on cardiovascular effects and potential advantages of GLP-1RA therapy in patients with HFpEF
At SemaPen, we often see people balancing their need for essential thyroid hormone replacement along with a desire for a more effective way to lose weight